16 August 2012
Juliet Bouverie, Director of Services, Macmillan Cancer Support, says:
“We welcome the release of this data. It is fantastic news that so many Trusts have improved in the experience they provide cancer patients in one year.
“However it is essential that this is the case across all cancer types. People who have rarer cancers should not be treated any worse than those with a common cancer.
“Macmillan believes that the NHS Commissioning Board now needs to ensure strong incentives are provided to the NHS so that commissioners are judged on patient experience as a measure of how they are performing.1”
For further information, please contact:
Andrea Shufflebotham, Senior Media & PR Officer,
0207 840 4689, (out of hours 07801 307068),
Notes to Editors:
1. Macmillan Cancer Support is calling for the NHS Commissioning Board to include an indicator based on the Cancer Patient Experience Survey in the Commissioning Outcomes Framework.
About Macmillan Cancer Support
Cancer is the toughest fight most of us will ever face. But you don’t have to go through it alone. The Macmillan team is with you every step of the way.
We are the nurses and therapists helping you through treatment. The experts on the end of the phone. The advisers telling you which benefits you’re entitled to. The volunteers giving you a hand with the everyday things. The campaigners improving cancer care. The fundraisers who make it all possible.
We are Macmillan Cancer Support